These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 3373756)

  • 1. [Recent developments in synergistic drugs for protective factors in peptic ulcer--clinical efficacy and problems; ulcer-surface protective drugs].
    Tsukamoto Y; Nakazawa S
    Nihon Rinsho; 1988 Jan; 46(1):45-9. PubMed ID: 3373756
    [No Abstract]   [Full Text] [Related]  

  • 2. [Recent developments of drugs antagonistic to factors causing peptic ulcer--clinical efficacy and problems; pepsin inhibitors].
    Itoh T; Ishikawa T
    Nihon Rinsho; 1988 Jan; 46(1):39-44. PubMed ID: 3131559
    [No Abstract]   [Full Text] [Related]  

  • 3. [Various problems on refractory peptic ulcers; progress of drug therapy and changes in the concept of peptic ulcer].
    Ishimori A; Kawamura T
    Nihon Rinsho; 1988 Jan; 46(1):146-51. PubMed ID: 3373747
    [No Abstract]   [Full Text] [Related]  

  • 4. Mucosa protectives: sucralfate and colloidal bismuth subcitrate in peptic ulcer disease.
    Tytgat GN; Nio CY
    Z Gastroenterol; 1987 Aug; 25 Suppl 3():152-61. PubMed ID: 3660894
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Recent developments in synergistic drugs for protective factors in peptic ulcer--clinical efficacy and problems; mucosal blood-flow improving agents].
    Shimakura S; Fukutomi H
    Nihon Rinsho; 1988 Jan; 46(1):55-63. PubMed ID: 3373758
    [No Abstract]   [Full Text] [Related]  

  • 6. The mechanism of protective, therapeutic and prophylactic actions of sucralfate.
    Tarnawski A; Hollander D; Gergely H
    Scand J Gastroenterol Suppl; 1987; 140():7-13. PubMed ID: 3481883
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of protective drugs in the prevention of ulcer relapse.
    Ota S; Terano A
    J Gastroenterol; 1994 Jul; 29 Suppl 7():139-40. PubMed ID: 7921147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Recent developments in drugs antagonistic to factors causing peptic ulcer--clinical efficacy and problems; gastric mucosa proton pump inhibitors].
    Okabe S; Akimoto Y
    Nihon Rinsho; 1988 Jan; 46(1):33-8. PubMed ID: 2836641
    [No Abstract]   [Full Text] [Related]  

  • 9. [Sucralfate protects the ulcer from acids and pepsin].
    von Bocko Polach U
    Med Klin; 1980 Oct; 75(21):764-7. PubMed ID: 6779100
    [No Abstract]   [Full Text] [Related]  

  • 10. [Changes in the transmural electric potential difference in the region of stomach ulcer. Local effect of sucralfate, aluminum hydroxide and magnesium trisilicate].
    Möckel W; Hausding P
    Fortschr Med; 1984 Jul; 102(25-26):709-12. PubMed ID: 6547921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of peptic ulcer disease with sucralfate: a review.
    Hunt RH
    Am J Med; 1991 Aug; 91(2A):102S-106S. PubMed ID: 1882894
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topically active drugs in the treatment of peptic ulcers. Focus on colloidal bismuth subcitrate and sucralfate.
    Bianchi Porro G; Parente F
    J Clin Gastroenterol; 1992 Apr; 14(3):192-8. PubMed ID: 1348753
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of peptic aggression by sucralfate. The view from the ulcer crater.
    Samloff IM
    Scand J Gastroenterol Suppl; 1983; 83():7-11. PubMed ID: 6415806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mucosal defence in ulcer disease. Proceedings of the Sucralfate Symposium. Copenhagen, 14-15 March 1986.
    Scand J Gastroenterol Suppl; 1987; 127():1-125. PubMed ID: 3475766
    [No Abstract]   [Full Text] [Related]  

  • 15. Acid, cytoprotection, and peptic ulcer. Introduction.
    Lam SK; Sabesin SM
    Am J Med; 1987 Sep; 83(3B):1-3. PubMed ID: 3661608
    [No Abstract]   [Full Text] [Related]  

  • 16. [Recent developments in synergistic drugs for protective factors in peptic ulcer--clinical efficacy and problems; tissue healing inducing drugs].
    Mori H; Sato H; Seki Y
    Nihon Rinsho; 1988 Jan; 46(1):50-4. PubMed ID: 3373757
    [No Abstract]   [Full Text] [Related]  

  • 17. [Special form of cytoprotection: a local protective layer on the peptic ulcer].
    Miederer SE; Haberland D
    Wien Med Wochenschr; 1983; 133(4-5):98-103. PubMed ID: 6344446
    [No Abstract]   [Full Text] [Related]  

  • 18. [Recent developments in synergistic drugs for protective factors in peptic ulcer--clinical efficacy and problems; prostaglandins].
    Arakawa T; Kobayashi K
    Nihon Rinsho; 1988 Jan; 46(1):64-8. PubMed ID: 3131560
    [No Abstract]   [Full Text] [Related]  

  • 19. [Treatment of peptic ulcer with sucralfate].
    Brailski Kh; Mendizova A; Matov V; Dimitrov B
    Klin Med (Mosk); 1991 Aug; 69(8):78-80. PubMed ID: 1791718
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of peptic ulcers--acid reduction or cytoprotection?
    Glise H; Carling L; Hallerbäck B; Kagevi I; Solhaug JH; Svedberg LE; Wahlby L
    Scand J Gastroenterol Suppl; 1987; 140():39-47. PubMed ID: 3328284
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.